NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
Explore clinical trials studying Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8. Study availability and eligibility vary by location and protocol.
14 public trials
2 recruiting studies
Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 trial results
NCT04771520
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, +58 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
NCT03801876
- Conditions
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, +10 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
Active, not recruiting
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers
NCT04460937
- Conditions
- Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
NCT05041153
- Conditions
- Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8, +30 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
NCT05836584
- Conditions
- Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, +7 more
- Locations
-
- Kaiser Permanente Dublin Dublin, California, United States
- Kaiser Permanente-Fremont Fremont, California, United States
- Kaiser Permanente-Fresno Fresno, California, United States
- Kaiser Permanente-Modesto Modesto, California, United States
Active, not recruiting
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
NCT04929392
- Conditions
- Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +31 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer
NCT03776487
- Conditions
- Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, +25 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827
- Conditions
- Abdominal Neoplasms, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
- Conditions
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Related conditions
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (11)
- Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 (10)
- Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (8)
- Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 (8)
- Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (8)
- Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 (7)
- Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 (7)
- Clinical Stage IVA Gastric Cancer AJCC v8 (6)